首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1.
【24h】

Mutations in LRRK2/dardarin associated with Parkinson disease are more toxic than equivalent mutations in the homologous kinase LRRK1.

机译:与帕金森氏病相关的LRRK2 / dardarin突变比同源激酶LRRK1的等效突变更具毒性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Several mutations have been found in the leucine-rich repeat kinase 2 gene (LRRK2), encoding the protein dardarin, which are associated with autosomal dominant Parkinson disease. We have previously shown that mutant LRRK2/dardarin is toxic to neurons and neuron-like cell lines in culture and that some mutations are also associated with an inclusion-body phenotype. There is a homologous kinase, LRRK1, which has a similar domain structure but is not known to carry mutations causing Parkinson disease. In the current study, we introduced mutations at equivalent residues in both LRRK2 and LRRK1 to determine their effects in cells. We show that mutations in dardarin are more prone to form inclusion bodies in transfected cells and are more toxic than equivalent mutations in LRRK1. This work suggests that dardarin/LRRK2 is inherently more damaging than LRRK1.
机译:在富含亮氨酸的重复激酶2基因(LRRK2)中发现了几个突变,这些突变编码蛋白质dardarin,与常染色体显性帕金森氏病相关。先前我们已经表明,突变体LRRK2 / dardarin对培养物中的神经元和神经元样细胞系具有毒性,并且某些突变也与包涵体表型有关。有一个同源的激酶,LRRK1,具有相似的结构域结构,但未知携带引起帕金森氏病的突变。在当前的研究中,我们在LRRK2和LRRK1的等效残基处引入了突变,以确定它们在细胞中的作用。我们显示,dardarin中的突变比LRRK1中的等效突变更容易在转染细胞中形成包涵体,并且毒性更高。这项工作表明,dardarin / LRRK2本质上比LRRK1更具破坏性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号